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The diagnosis and treatment of cutaneous in
fections appear to be rather straightforward al first
glance. Major texts of pediatrics and dermatology
indicate that the vast majority of pyodermas are due
to either Staphylococcus aureus (S. aureus) or
Streptococcus pyogenes and that antibiotics are cura
tive. On closer scrutiny, however, one quickly be
comes aware that there is a great deal of nomencla
tural confusion with a corresponding lack of clarity
regarding therapy-particularly on the point of
whether or not topical antibiotics have any place in
therapy.
Pyodermas can be divided into two main classes:
primary and secondary. In a primary pyoderma. the
skin is normal or at most has suffered a minor cut.
abrasion, or insect bite. In such a situation. the in
vading organism is entirely responsible for the clini
cal picture. The situation is entirely different in a
secondary infection. Here the underlying process is a
chronic inflammatory process, for example. atopic
dermatitis which first becomes colonized, usually by
S. aureus. and secondary infection is present only
when S. aureus has proliferated to rather high levels
(see below).
Primary Cutaneous Infections.

Two distinct forms of primary pyodermas have
been described: I) Bullous impetigo caused by Group
II S. aureus usually phage type 71. and 2) Streptococ
cal pyoderma or ecthyma due to Group A beta he
molytic streptococci. Both have distinctive clinical
characteristics which can allow confident diagnosis.
Bullous impetigo presents as multiple, often coaFrom the University of Pennsylvania. Derartment of Derma
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lescing superficial bullae which rupture easily and
leave behind a thin varnish-like crust. This eruption is
usually seen in children. most commonly on the face.
although any part of the body may be involved. Fever
and other systemic signs are infrequent. Therapy con
sists of oral antibiotics. either penicillin G 400.000
units q.i.d. for ten days or oxacillin 500 mg q.i.d. if a
penicillinase producing organism is involved. Local
care of compresses and topical antibiotic or ster
oid-antibiotic creams are useful. This form of pyo
derma is rather contagious. but does not carry with it
the potential for post-infection glomerulonephritis.
A severe and fortunately rare form of S. aureus
infection is the toxic epidermal necrolysis syndrome.
A toxin mediated by phage type 71 S. aureus causes
widespread necrosis of the epidermis and results in a
sloughing off skin. producing the so-called "scaled
skin syndrome." The infecting organism is usually in
the nasopharynx. ear. or conjunctiva and not in the
skin. Treatment consists of intravenous penicillin
(Nafcillin 50 mg/kg) until the lesion ceases to appear
and then oral Nafcillin for seven to ten more days.
Streptococcal pyoderma begins as superficial
vesicles. but quickly erodes and develops a central
ulceration with a thick crust and an areola of er
ythema surrounding the ulceration.' These lesions
occur primarily on the lower extremities of children
during the hot, humid summer months and are fre
quently associated with lymphadenopalhy and fever.
Streptococcal skin infections do not result from the
strains responsible for throat infections and anti
slreptolysin-0 (ASO) titers are feeble. although an
tibody response lo other streptococcal antigens
(DA N-ase B and hyaluronidase) can be vigorous.'
Cultures reveal Group A streptococci under the crust
and under the edges of the advancing ulceration while
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the crust itself may reveal only S. aureus. Treatment
studies in both humans and in hamsters support the
view that streptococci are the important agents since
the presence of penicillin-resistant staphylococci in
mixed lesions does not interfere with effective treat
ment with penicillin G. 3·' It is this streptococcal vari
ety of pyoderma which carries the risk of post-in
fection glomerulonephritis. There are no studies
demonstrating the prevention of glomerulonephritis
by penicillin treatment and in fact there is consid
erable clinical evidence to suggest that renal com
plications may occur despite penicillin treatment.'
Treatment consists of benzathine penicillin 2.4
million units intramuscularly for extensive deep
seated lesions.• The role of topical antibiotics is un
settled. Several studies comparing topical to systemic
therapy concluded that systemic therapy was supe
rior. However. no attempt was made to separate
deep. extensive lesions from the early more super
ficial variety. Our own view is that in early lesions.
compresses and topical antibiotics are quite effec
tive.'
Secondary Infections: lmpetiginization.

Inflamed skin provides fertile soil for bacterial
overgrowth. and it is not surprising that dermatitic
skin can become colonized and then infected with
various pathogens. In most cases. the organism in
volved is a S. aureus. A variety of phage types are
found. but rarely are the highly virulent strains such
as type 71 isolated. Beta hemolytic streptococci are
rarely recovered from dermatoscs: in several hundred
studied cases we have found five examples of Group
A beta hemolytic streptococci complicating an under
lying disorder-two were in epidcrmolytic hyperkera
tosis and the other three occurred as severe "athlete's
foot" infections.' Candida a/hicans and gram-nega
tives are found in two situations. namely in derma
toses occurring in wet body regions and in patients on
long-term antibiotic therapy.
The question arises of when does the recovery of
an organism from a dermatosis indicate infection is
present and that antibiotic therapy is indicated.
Through our quantitative studies we have to date
evolved to an understanding of the r·ollowing guide
lines for interpretation of routine non-quantitative
culture reports.
I. Normal Aerobic llora-non-pathogcns.
Staphrlococcu.1· cpider111idi s ( S cpidem1idi.1 ). lipo
philic dipthcroids.
2. Gra111-11c!{atiues.
Thc rclativc virukncc ol. thcsc organisms has not

been fully established as yet. Pseudomonas certainly
appears to be relatively virulent. but the density re
quired to aggrevate an underlying dermatosis and
the density of Escherichia coli IE. coli). Proteus, and
others have not been elucidated. These organisms can
be found in low numbers in wet body areas such as
the groin. axilla. and toe space. and at low numbers
these organisms do not damage intact human skin.
Present evidence would suggest that a useful guide
line would be that if a culture reveals the predo111i11a111 organism to be a gram-negative. then it most
likely is contributing to the clinical picture. The
choice of an antibiotic would be one that would in
clude activity against the gram-negative isolated.
3. Candida a/hicans.
Our experience with this organism in experi
mental infection situations has taught us that it is
extremely toxic to human skin. A far lower inoculum
is needed to induce an infection than with any other
organism we have studied to date. For example. as
low as ten Candida cells will result in a severe reaction
after three to four days of growth under saran wrap
while thousands of cells and prior suppression of the
resident nora are required for experimental S. aureus
infections.• ' 0 The isolation of C. albicans from a der
matitis such as diaper dermatitis is therefore a very
signilicant linding. and anti-yeast measures are in
dicated.
4. Propio11ibacteriw11.
Two main groups have been identified: P. acnes
which is susceptible to P. acnes bacteriophage is more
prevalent and found in greater densities in the se
baceous areas than is the phage-resistant P. gran
ulosu111. Recovery of this organism from a skin cul
ture does not indicate an infection. rather it is a
member of the resident llora. This organism does.
however. appear to play a central role in acne vul
garis. Acne patients carry a much greater density of
this organism than do aged-matched controls." The
current hypothesis is that this organism influences the
acne process by virtue of production of free fatty
acids through hydrolysis of sebaceous gland triglyc
erides. Those antibiotics which lower P. acnes in vivo
such as tetracyclinc. erythromycin. and clindamycin
arc also Judged to be useful in the management of
acne. while penicillin and sulfonamides neither lower
P. acnes nor help in the treatment of this disorder. To
d;1tc. wc have not encountered P. ac11es resistant to
;1ntibiotics. and clinical failure during antibiotic ther
apy does not indicate that another factor is involved.
for example. hormonal disturbance. emotional dis-
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tress. or other factors. To dale. only systemic antibi
otics have heen round to lower P acnes levels. Re
cently. however. there is some evidelll:e suggesting
that topical henLoyl peroxide may he an effective
agent ror suppressing P. acnes.
:i. S. (/1/J'<'l/S.
S1aphrlococrns aureus is the usual organism re
covered from in Ilamed skin. A \'ariety or phage types
are reco,·ered: ,·irulenl strains su,h as type 71 are not
fre4uenl. In a series or studies. we ha,·e established
that a density or one million S. aureus organisms per
s4 <.:111 is the le,·el al ,,·hich antibiotic therapy ,,ill
produ,e clinical improvement." Our definition or a
S. aureus secondarily infe,ted dermatosis is thererore
expressed in quantitative terms. Certain eruptions rar
more commonly harbor levels or S. aureus e.,ceeding
our established quantitative criteria for presence or a
secondary infection. In atopic dermatitis. as many as
45", of even the chronic li,henilied ,·ariety and I ooc;
or the acute exudative form will harbor more than a
million S. aureus per sq cm. In such cases. even
though overt clinical signs of infe,tion are lacking.
topical or systemic therapy will produce a rapid sup
pression of this organism in one week's time and
result in clinical improvement. Other conditions fre
quently harboring more than a million S. aureus per
sq cm include numular eczema. neurodermatitis. ex
foliative erythrodermas. and chronic ramilial benign
pemphigus. and again antibiotic therapy will orten be
useful in these conditions. In psoriasis and seborrheic
dermatitis. S. aureus very rarely achieves a high
enough density lo be clinically signilicant. and antibi
otic therapy is rarely useful except when S. aureus
growth has been stimulated. which can happen. ror
example. during occlusive therapy with impermeable
plastic film. An important corollary of this principle
of the quantitative aspect of S. aureus secondary in
fections is the role of steroids in such conditions. One
might predict that topical steroids could lead to an
aggravation of a condition heavily coloniLed with S.
aureus. Clinical experience does not support the the
ory. however. The explanations for this apparent par
adox is that topical steroids are effective in suppress
ing the inllammalion which promotes S. aureus
coloniLation and proliferation. By removing the con
ditions favoring S. aureus growth, the return of the
normal protective flora is promoted rather than S.
aureus overgrowth.
Therapeutic Approaches.
In primary infections such as bullous impetigo,
ecthyma, and cellulitis, systemic antibiotic therapy is
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rnralive be,ause invading pathogenic bacteria are re
sponsible for the entire clinical picture. Local com
presses lo n;move crusts and topical steroids to sup
prcs, rnlaneous inllammation are useful adjuncts.
hut the main thrust of therapy is lo remove the of
fending pathogen.
In secondarily infected dermaloses. a variety of
therapeutic approa,hes are available and often sev
eral modalities must be simultaneously utilized. Both
topical and systemic antibiotics are effective. and
,hoi,e is determined principally by the extent and
severity or involvement. Steroids are indicated for
suppression or the underlying inllammalory condi
tion. whi<.:h promotes a more normal skin and the
return of the normal tlora. The combination of ster
oids and antibiotics appears to offer a rational ap
proa<.:h.
1 n excessively wet areas such as the axilla. groin.
and toe web space. and in severely exudative lesions
anp,·here. therapy must also include "drying"
agents. Excessive moisture promotes bacterial growth
and must be controlled in order to obtain satisfactory
results. Tht: use or compresses is often indicated.
Dyes such as gentian violet and Castellani's paint
which have both astringent and antimicrobial activity
provide a double-pronged approach.
The object of therapy should be to restore the
skin to a nonintlamed status and to promote return of
the normal protective residenl microtlora. Antibiotics
are used to remove pathogens. steroids suppress in
llammation. and compresses remove excessive mois
ture. Successrul therapy involves attacking all aspects
of a disorder.
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